全文获取类型
收费全文 | 4004篇 |
免费 | 270篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 71篇 |
妇产科学 | 54篇 |
基础医学 | 534篇 |
口腔科学 | 49篇 |
临床医学 | 501篇 |
内科学 | 721篇 |
皮肤病学 | 28篇 |
神经病学 | 475篇 |
特种医学 | 208篇 |
外科学 | 516篇 |
综合类 | 49篇 |
一般理论 | 9篇 |
预防医学 | 455篇 |
眼科学 | 54篇 |
药学 | 278篇 |
中国医学 | 8篇 |
肿瘤学 | 212篇 |
出版年
2023年 | 36篇 |
2022年 | 67篇 |
2021年 | 119篇 |
2020年 | 75篇 |
2019年 | 123篇 |
2018年 | 137篇 |
2017年 | 90篇 |
2016年 | 109篇 |
2015年 | 140篇 |
2014年 | 163篇 |
2013年 | 218篇 |
2012年 | 316篇 |
2011年 | 327篇 |
2010年 | 195篇 |
2009年 | 128篇 |
2008年 | 265篇 |
2007年 | 243篇 |
2006年 | 210篇 |
2005年 | 235篇 |
2004年 | 195篇 |
2003年 | 170篇 |
2002年 | 192篇 |
2001年 | 47篇 |
2000年 | 55篇 |
1999年 | 54篇 |
1998年 | 32篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 17篇 |
1994年 | 13篇 |
1993年 | 18篇 |
1992年 | 21篇 |
1991年 | 35篇 |
1990年 | 23篇 |
1989年 | 12篇 |
1988年 | 19篇 |
1987年 | 12篇 |
1986年 | 15篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1981年 | 5篇 |
1980年 | 11篇 |
1979年 | 9篇 |
1978年 | 7篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 8篇 |
1970年 | 5篇 |
排序方式: 共有4290条查询结果,搜索用时 8 毫秒
241.
Past reports suggest that reduced P300 amplitude is associated with risk for alcoholism. We examined whether visual P300 amplitude could identify familial risk for alcohol disorders in individuals not known to be at risk at the time P300 was recorded. These individuals were twins from pairs where neither twin had an alcohol disorder at age 17 but familial risk was established at age 20 when one twin developed an alcohol disorder whereas the other did not. Of special interest was the P300 of the unaffected twin recorded at age 17 when both twins were alcoholism free. We found reduced P300 in the unaffected twin compared to pairs where both members were continuously disorder free. Hence, P300 was reduced in alcohol disorder-free individuals whose twin siblings subsequently developed alcoholism, further supporting reduced P300 amplitude as an endophenotype indexing familial risk for alcoholism. 相似文献
242.
243.
Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres. 总被引:8,自引:0,他引:8
Cory Berkland Matt J Kipper Balaji Narasimhan Kyekyoon Kevin Kim Daniel W Pack 《Journal of controlled release》2004,94(1):129-141
A thorough understanding of the factors affecting drug release mechanisms from surface-erodible polymer devices is critical to the design of optimal delivery systems. Poly(sebacic anhydride) (PSA) microspheres were loaded with three model drug compounds (rhodamine B, p-nitroaniline and piroxicam) with a range of polarities (water solubilities). The drug release profiles from monodisperse particles of three different sizes were compared to release from polydisperse microspheres. Each of the model drugs exhibited different release mechanisms. Drug distribution within the polymer was investigated by laser scanning confocal microscopy and scanning electron microscopy. Rhodamine, the most hydrophilic compound investigated, was localized strongly toward the microsphere surface, while the much more hydrophobic compound, piroxicam, distributed more evenly. Furthermore, all three compounds were most uniformly distributed in the smallest microspheres, most likely due to the competing effects of drug diffusion out of the nascent polymer droplets and the precipitation of polymer upon solvent extraction, which effectively "traps" the drug in the polymer matrix. The differing drug distributions were manifested in the drug release profiles. Rhodamine was released very quickly independent of microsphere size. Thus, extended release profiles may not be obtainable if the drug strongly redistributes in the microspheres. The release of p-nitroaniline was more prolonged, but still showed little dependence on microsphere size. Hence, when water-soluble drugs are encapsulated with hydrophobic polymers, it may be difficult to tailor release profiles by controlling microsphere size. The piroxicam-loaded microspheres exhibit the most interesting release profiles, showing that release duration can be increased by decreasing microsphere size, resulting in a more uniform drug distribution. 相似文献
244.
245.
246.
247.
Evidence for public health policy on inequalities: 1: the reality according to policymakers 总被引:1,自引:1,他引:0 下载免费PDF全文
Petticrew M Whitehead M Macintyre SJ Graham H Egan M 《Journal of epidemiology and community health》2004,58(10):811-816
OBJECTIVE: To explore with UK and international policy advisors how research evidence influences public health policy making, and how its relevance and utility could be improved, with specific reference to the evidence on the production and reduction of health inequalities. DESIGN, SETTING, AND PARTICIPANTS: Qualitative residential workshop involving senior policy advisors with a substantive role in policy development across a range of sectors (mainly public health, but also including education, social welfare, and health services). In four in depth sessions, facilitated by the authors, focused questions were presented to participants. Their responses were then analysed thematically to identify key themes, relating to the availability and utility of existing evidence on health inequalities. MAIN RESULTS: The lack of an equity dimension in much aetiological and evaluative research was highlighted by participants. Much public health research was also felt to have weak underlying theoretical underpinnings. As well as evaluations of the effectiveness and cost-effectiveness of policy and other interventions, they identified a need for predictive research, and for methodological research to further develop methods for assessing the impact on health of clusters of interventions. CONCLUSIONS: This study reinforces the view that there is a lack of information on the effectiveness and cost-effectiveness of policies, and it uncovered additional gaps in the health inequalities evidence base. A companion paper discusses researchers' views of how the production of more relevant public health evidence can be stimulated. 相似文献
248.
249.
250.
Sinclair DB Aronyk K Snyder T McKean JD Wheatley M Gross D Bastos A Ahmed SN Hao C Colmers W 《Pediatric neurology》2004,30(3):177-185
There have been relatively few studies reporting the safety, efficacy, and outcome in children undergoing extratemporal resection for epilepsy. We reviewed the pediatric cases of extratemporal resection for intractable epilepsy performed by the Comprehensive Epilepsy Program at the University of Alberta Hospitals between 1988-1998. Thirty-five patients were studied, 14 male and 21 female. The age at operation ranged from 6 months to 16 years. The operations included frontal excisions (12), parietal (8), occipital (4), hemispherectomies or multilobar resections (10), and one removal of a hypothalamic hamartoma. The pathology at surgery included patients with focal cortical dysplasia (8), brain tumors (6), neurocutaneous syndrome (7), Rasmussen's encephalitis (2), porencephalic cysts (4), hypothalamic hamartoma (1), and nonspecific gliosis (6). Twenty-four of 35 patients (68.5%) had an Engel Class I outcome after surgery and an additional six patients (11%) had a significant decrease in seizure frequency (Engel Class III). Complications were observed in two patients (5%) and there were no deaths. Extratemporal resection is a safe and effective treatment for children with intractable epilepsy. Overall, 68% of patients were seizure-free after surgery, although outcome may be dependent on site and pathology. A wide range of developmental pathology was observed including focal cortical dysplasia, brain tumors, and lesions with neurocutaneous syndromes. Many families reported improvement in behavior and psychosocial function after surgery. 相似文献